SIM010
SIM010 - Males and Females, 18 - 55
Information file

- Age
- 18 - 55
- Smoking habits
- Non / Ex-smoker only
Body Mass Index (BMI)
- From
- 18
- To
- 32
Location
- Date
- TBC
- Return Visits
- 0
Details
Part A
A study to investigate a drug being developed for the treatment of Acute Optic Neuritis (AON), which can leave people temporarily blind or permanently blind in either one or both eyes. It is hoped that the drug will become a treatment for Multiple Sclerosis and other similar diseases.
Screening Visit 1 (to confirm your eligibility to enter the study)
Screening Visit 2 (EEG and MRI Scan)
Two treatment periods:
Treatment Period 1 3 overnight stays
Treatment Period 2 3 overnight stays
Follow Up Visit
Non smokers of 6 months or more
- Compensation
- £2500
Other available studies
![]() ![]() |
SIM001 (Smoker) | Age 65 and older | Compensation £3475 | ![]() |
![]() |
SIM007 (Non / Ex-smoker only) | Age 18 - 55 | Compensation £1375 | ![]() |
![]() |
SIM008 (Non / Ex-smoker only) | Age 45 and older | Compensation £2500 | ![]() |
![]() ![]() |
SIM009 (Smoker) | Age 18 - 75 | Compensation £4500 | ![]() |
![]() |
SIM011 (Non / Ex-smoker only) | Age 18 - 45 | Compensation £1300 | ![]() |
![]() ![]() |
SIM012 (Non / Ex-smoker only) | Age 18 - 55 | Compensation £5965 | ![]() |
![]() ![]() |
SIM004 (Smoker) | Age 23 - 55 | Compensation Up to £3500 | ![]() |
Please note
Study dates and availability may change at any time. There is no guarantee that these studies will still be available or that the dates will be the same when you contact our call centre. We do our best to ensure that the information published is up-to-date.
Information about the medication involved in the study is not provided on this Web site to respect the industry confidentiality. For more information about a specific study, please contact one of our call centre agents at 0800 691995.
Please note that during the in-house portion of the study you are expected to remain at our clinic throughout the entire duration of the stay. Although you are free to withdraw your participation at any time during the study, leaving the premises before the end of the intended stay, will result in the termination of your participation in the study.
Confidentiality
Simbec follows very rigorous personal information protection and safety policies and practises in accordance with the UK Data protection Act 1998.
Newsletter
I would like to receive your newsletter to be informed about available studies:
Why so many questions
Have questions about our clinical trial study process? See answers to commonly asked questions.